Project Number 20131207.01-MIELKE-2013 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2013 View Full Project Details for Evaluation of changes in plasma ceramides and amino compounds with an mTOT Modulator Insulin Sensitizer in AD patients Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 1. Fluid Biomarkers b. Blood-based Biomarkers Researcher and Organization Principal Investigator MIELKE, MICHELLE M Principal Investigator First Name MICHELLE M Principal Investigator Last Name MIELKE Awardee Organization MAYO CLINIC ROCHESTER Awardee State Minnesota Contact PI Country United States Project Detail Funding Opportunity Announcement General RFP FY Overall Cost $6,960 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States